PMID: 11061053Nov 4, 2000

Improved survival after acute myocardial infarction in patients with advanced Killip class

Clinical Cardiology
W L MillerS L Kopecky

Abstract

The continuing applicability of the Killip classification system to the effective stratification of long-term and short-term outcome in patients with acute myocardial infarction (MI) and its influence on treatment strategy calls for reanalysis in the setting of today's primary reperfusion treatments. Our study sought to test the hypothesis that Killip classification, established on admission in patients with acute MI, is an effective tool for early prediction of in-hospital mortality and long-term survival. A series of 909 consecutive Olmsted County patients admitted with acute MI to St. Marys Hospital, Mayo Clinic, between January 1988 and March 1998 was analyzed. Killip classification was the primary variable. Endpoints were in-hospital death, major in-hospital complications, and post-hospital death. Patients analyzed included 714 classified as Killip I, 170 classified as Killip II/III, and 25 classified as Killip IV. Increases in in-hospital mortality and prevalence of in-hospital complications correspond significantly with advanced Killip class (p < 0.01), with in-hospital mortality 7% in class I, 17.6% in classes II/III, and 36% in class IV patients (p < 0.001). Killip classification was strongly associated with mode of th...Continue Reading

References

Oct 8, 2013·International Heart Journal·Chang Seong KimKorea Acute Myocardial Infarction Registry Investigators
Feb 6, 2016·International Journal of Cardiology·Wei Ren ChenQing Xiu Ning
Oct 5, 2010·The American Journal of Emergency Medicine·Hsien-Hung Cheng, Pai-Chun Yen
Dec 13, 2016·Circulation. Cardiovascular Imaging·Wei Ren ChenXiao Fang Gu
May 8, 2018·Archivos de cardiología de México·Manuel Chacón-DiazPatricia Rebaza-Miyasato
Mar 24, 2005·The American Heart Hospital Journal·W H Wilson Tang, Gary S Francis
Sep 10, 2020·Frontiers in Cardiovascular Medicine·Jianhua YaoJiahong Xu

Citations

Mar 11, 1992·Journal of the American College of Cardiology·M D HibbardB J Gersh
Mar 1, 1991·Journal of the American College of Cardiology·L LeeW W O'Neill
Feb 1, 1988·The American Journal of Cardiology·C DuboisH E Kulbertus
Feb 8, 1969·Lancet·R M NorrisP J Scott
Feb 1, 1973·British Heart Journal·B L Chapman, C H Gray
Dec 1, 1970·The American Journal of Cardiology·S ScheidtT Killip
Oct 1, 1967·The American Journal of Cardiology·T Killip, J T Kimball
Jul 1, 1984·American Heart Journal·R F GillumT E Kottke
Feb 15, 1994·The American Journal of Cardiology·J S JenkinsG F Petroski
Dec 24, 1997·JAMA : the Journal of the American Medical Association·W D WeaverF Ribichini
May 23, 1998·The New England Journal of Medicine·Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS)
Jun 19, 1998·Clinical Cardiology·D L DriesB J Gersh
Aug 26, 1998·The New England Journal of Medicine·S S GottliebR A Vogel

Related Concepts

Survival Analysis
Logistic Regression
Myocardial Infarction
Hospital Mortality
Acute Disease
Bikinia le-testui
X-Linked Combined Immunodeficiency Diseases
Physiological Reperfusion
Cox Proportional Hazards Models
Relapse

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.